Blau Farmacêutica S.A. - Laporan Laba Rugi (TTM)

Blau Farmacêutica S.A.
BR ˙ BOVESPA ˙ BRBLAUACNOR8
R$ 13.81 ↓ -0.04 (-0.29%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Blau Farmacêutica S.A. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 1,066 1,182 1,289 1,338 1,354 1,366 1,354 1,348 1,390 1,407 1,352 1,351 1,352 1,373 1,474 1,575 1,686 1,754 1,768 1,767
Change (%) 10.84 9.06 3.77 1.26 0.89 -0.94 -0.41 3.12 1.21 -3.92 -0.07 0.08 1.54 7.39 6.84 7.04 4.07 0.76 -0.02
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 567 626 662 661 675 700 697 719 737 739 738 752 820 882 972 1,054 1,089 1,096 1,079 1,061
Change (%) 10.45 5.84 -0.15 1.99 3.84 -0.48 3.20 2.51 0.21 -0.14 1.91 9.00 7.64 10.11 8.52 3.32 0.58 -1.51 -1.65
% of Revenue 53.14 52.96 51.39 49.45 49.81 51.26 51.50 53.37 53.05 52.53 54.60 55.68 60.64 64.28 65.91 66.95 64.62 62.45 61.05 60.05
Gross Operating Profit 500 556 627 676 680 666 657 629 653 668 614 599 532 490 503 521 596 659 689 706
Change (%) 11.28 12.69 7.92 0.54 -2.04 -1.41 -4.24 3.81 2.34 -8.10 -2.45 -11.13 -7.86 2.51 3.58 14.58 10.44 4.53 2.54
% of Revenue 46.86 47.04 48.61 50.55 50.19 48.74 48.50 46.63 46.95 47.47 45.40 44.32 39.36 35.72 34.09 33.05 35.38 37.55 38.95 39.95
SG&A 136 162 175 186 193 204 210 213 231 214 217 231 246 160 180 187 184 318 320 332
Change (%) 18.78 8.17 6.44 3.56 5.62 2.78 1.52 8.58 -7.43 1.48 6.30 6.65 -35.08 12.75 4.09 -1.61 72.69 0.62 3.76
% of Revenue 12.78 13.70 13.59 13.94 14.25 14.92 15.48 15.78 16.62 15.20 16.05 17.08 18.20 11.64 12.22 11.90 10.94 18.15 18.13 18.81
R&D
Change (%)
% of Revenue
OpEx 703 793 844 855 876 910 910 935 967 955 958 987 948 924 1,028 1,143 1,301 1,416 1,367 1,335
Change (%) 12.79 6.47 1.25 2.50 3.87 0.06 2.68 3.47 -1.29 0.39 2.93 -3.87 -2.54 11.24 11.18 13.80 8.81 -3.42 -2.34
% of Revenue 65.91 67.07 65.48 63.89 64.67 66.58 67.25 69.34 69.57 67.86 70.91 73.03 70.16 67.34 69.76 72.59 77.17 80.69 77.34 75.55
Operating Income 363 389 445 483 478 457 443 413 423 452 393 364 403 448 446 432 385 339 400 432
Change (%) 7.07 14.34 8.56 -0.95 -4.56 -2.92 -6.76 2.33 6.91 -13.03 -7.37 10.75 11.11 -0.54 -3.18 -10.84 -11.97 18.21 7.91
% of Revenue 34.09 32.93 34.52 36.11 35.33 33.42 32.75 30.66 30.43 32.14 29.09 26.97 29.84 32.66 30.24 27.41 22.83 19.31 22.66 24.45
Interest Expense -12 -15 -18 -19 -24 -27 -27 -31 -33 -32 -30 -26 -24 -32 -43 -54 -66 -58 -58 -56
Change (%) 25.32 18.51 7.22 25.15 10.00 1.32 13.18 6.21 -0.63 -7.23 -12.81 -7.37 32.15 33.90 26.04 22.23 -11.96 -0.76 -3.51
% of Revenue -1.15 -1.30 -1.41 -1.46 -1.80 -1.96 -2.01 -2.28 -2.35 -2.31 -2.23 -1.94 -1.80 -2.34 -2.92 -3.44 -3.93 -3.32 -3.27 -3.16
Net Income 238 254 309 335 354 325 301 313 314 363 354 312 317 250 238 216 187 217 268 283
Change (%) 6.75 21.53 8.33 5.64 -8.06 -7.60 4.30 0.04 15.89 -2.62 -11.76 1.56 -21.22 -4.75 -9.27 -13.36 16.12 23.41 5.45
% of Revenue 22.34 21.52 23.98 25.03 26.12 23.80 22.20 23.25 22.56 25.83 26.18 23.11 23.46 18.20 16.14 13.71 11.10 12.38 15.16 15.99

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista